Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China.

about

Atherogenic index of plasma is a novel and better biomarker associated with obesity: a population-based cross-sectional study in China.

Item

http://www.wikidata.org/entity/Q52673509

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Atherogenic index of plasma is ...... ross-sectional study in China.

@en

Atherogenic index of plasma is ...... ross-sectional study in China.

@nl

type

Item

label

Atherogenic index of plasma is ...... ross-sectional study in China.

@en

Atherogenic index of plasma is ...... ross-sectional study in China.

@nl

prefLabel

Atherogenic index of plasma is ...... ross-sectional study in China.

@en

Atherogenic index of plasma is ...... ross-sectional study in China.

@nl

P1476

Atherogenic index of plasma is ...... ross-sectional study in China.

@en

P2093

Hui Zhou

http://www.w3.org/2001/XMLSchema#string

Jiarong Hu

http://www.w3.org/2001/XMLSchema#string

Lugang Yu

http://www.w3.org/2001/XMLSchema#string

Nengjun Yi

http://www.w3.org/2001/XMLSchema#string

Qinhua Ma

http://www.w3.org/2001/XMLSchema#string

Shufeng Lei

http://www.w3.org/2001/XMLSchema#string

Ting Lei

http://www.w3.org/2001/XMLSchema#string

Wenxin Xu

http://www.w3.org/2001/XMLSchema#string

Xiaohua Zhou

http://www.w3.org/2001/XMLSchema#string

Xiaowei Zhu

http://www.w3.org/2001/XMLSchema#string

P2860

Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants

2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

Small Dense Low-Density Lipoprotein as Biomarker for Atherosclerotic Diseases.

ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS).

Pathogenic potential of adipose tissue and metabolic consequences of adipocyte hypertrophy and increased visceral adiposity.

Association of serum hs-CRP and lipids with obesity in school children in a 12-month follow-up study in Japan

Lipoprotein ratios: Physiological significance and clinical usefulness in cardiovascular prevention.

Obesity, adiposity, and dyslipidemia: a consensus statement from the National Lipid Association.

Meta-analysis of Atherogenic Index of Plasma and other lipid parameters in relation to risk of type 2 diabetes mellitus.

Triglyceride to High-Density Lipoprotein Cholesterol Ratio and Cardiovascular Events in Diabetics With Coronary Artery Disease.

P2888

s12944-018-0686-8

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12944-018-0686-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-03-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101334283

http://www.w3.org/2001/XMLSchema#string

P698

29506577

http://www.w3.org/2001/XMLSchema#string

P921

atherosclerosis

P932

5836428

http://www.w3.org/2001/XMLSchema#string